| abstract |
The present invention is generally a muscarinic receptor antagonist, a compound of the general formula (I), wherein p, R 1 , R 2 , R 3 and A are described in the specification, Alternatively, it relates to individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, methods for their preparation and their use as therapeutic agents. |